Thomas Glaab
Overview
Explore the profile of Thomas Glaab including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
32
Citations
931
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Glaab T, Taube C
Respir Res
. 2022 Jan;
23(1):9.
PMID: 35022059
Unexplained exertional dyspnoea or fatigue can arise from a number of underlying disorders and shows only a weak correlation with resting functional or imaging tests. Noninvasive cardiopulmonary exercise testing (CPET)...
2.
Glaab T, Bohme K, Griesinger J, Forster A, Streitlein-Bohme I
Dtsch Med Wochenschr
. 2021 Sep;
146(18):1226-1229.
PMID: 34521129
The non-standardized oral specialist examination is the final step of the specialist medical training in Germany. The debate on its current format has long been at the centre of discussions...
3.
Glaab T, Braun A
Lung
. 2021 May;
199(3):255-261.
PMID: 34009429
Mouse models have become an indispensable tool in translational research of human airway disease and have provided much of our understanding of the pathogenesis of airway disease such as asthma....
4.
Kondla A, Glaab T, Pedersini R, Lommatzsch M
Respir Med
. 2016 Sep;
118:58-64.
PMID: 27578472
Background: The prevalence and the characteristics of poor asthma control among adults treated with combinations of inhaled corticosteroids (ICS) and long-acting beta-agonists (LABA) are not completely understood. Methods: Data from...
5.
Sauer R, Hansel M, Buhl R, Rubin R, Frey M, Glaab T
Int J Chron Obstruct Pulmon Dis
. 2016 May;
11:891-8.
PMID: 27217742
Background: Maintaining and improving physical functioning is key to mitigating the cycle of deconditioning associated with chronic obstructive pulmonary disease (COPD). We evaluated the impact of free combination of the...
6.
Rabe K, Fabbri L, Israel E, Kogler H, Riemann K, Schmidt H, et al.
Lancet Respir Med
. 2014 Jan;
2(1):44-53.
PMID: 24461901
Background: The effect of β2-adrenergic receptor (ADRB2) polymorphisms on the treatment response to longacting bronchodilators in chronic obstructive pulmonary disease (COPD) is unclear. We aimed to establish whether ADRB2 polymorphisms...
7.
Stephan M, Suhling H, Schade J, Wittlake M, Tasic T, Klemann C, et al.
Physiol Rep
. 2013 Dec;
1(5):e00095.
PMID: 24303167
The CD26-associated enzymatic activity of dipeptidyl peptidase-4 (DPP4) as well as the recruitment of CD26(+) T cells increase under allergic airway inflammation. Furthermore, genetic deficiency of CD26/DPP4 exerts protective effects...
8.
Beeh K, Glaab T, Stowasser S, Schmidt H, Fabbri L, Rabe K, et al.
Respir Res
. 2013 Oct;
14:116.
PMID: 24168767
Background: Data examining the characteristics of patients with frequent exacerbations of chronic obstructive pulmonary disease (COPD) and associated hospitalisations and mortality are scarce. Methods: Post-hoc analysis of the Prevention Of...
9.
Rabe K, Fabbri L, Vogelmeier C, Kogler H, Schmidt H, Beeh K, et al.
Chest
. 2012 Nov;
143(3):711-719.
PMID: 23188489
Background: There is still a lack of data on the seasonality of exacerbations of COPD based on large randomized studies using COPD exacerbations as primary end points. The objective of...
10.
Effect of tiotropium vs. salmeterol on exacerbations: GOLD II and maintenance therapy naïve patients
Vogelmeier C, Fabbri L, Rabe K, Beeh K, Schmidt H, Metzdorf N, et al.
Respir Med
. 2012 Oct;
107(1):75-83.
PMID: 23102611
The objective of this study was to investigate the effect of tiotropium compared with salmeterol on exacerbations in patients with moderate (Global Initiative for Chronic Obstructive Lung Disease [GOLD] stage...